Merck To Improve R&D Output By Having More Clues At The Start
Executive Summary
Merck's strategy for increasing its research and development productivity relies upon gaining more information about compounds and targets earlier in development, Merck Research Labs President Peter Kim said Dec. 12
You may also be interested in...
Biotechs Gain On Favorable M&A Landscape; Will Deal Prices Keep Rising?
The steady growth in the valuation of small and mid-size biotech firms over the last quarter may reflect the increasing leverage such companies have in merger and acquisition negotiations with big pharma
Biotechs Gain On Favorable M&A Landscape; Will Deal Prices Keep Rising?
The steady growth in the valuation of small and mid-size biotech firms over the last quarter may reflect the increasing leverage such companies have in merger and acquisition negotiations with big pharma
Pfizer’s Manufacturing Cost-Cutting May Leave Little Capacity For Growth
Following its restructuring, Pfizer's in-house manufacturing capacity will support approximately $48 billion in sales